Emyria Limited (ASX:EMD) is pleased to share a video from the recent ShareCafe Small Cap “Hidden Gems” Webinar. 

EMD Managing Director, Dr Michael Winlo, provided an overview of the Company’s advances in clinical drug development and care delivery, including its recent Ethics Approval for EMD-RX5 and expanded proprietary MDMA analogue library, to be used for psychedelic assisted therapies and other neuropsychiatric disorders.

Click here to read the presentation slide deck. Watch this video to see what Dr Michael Winlo has to say too, with a Q&A at 13 minutes in: